Importantly, IgA, IgG3 and FcγR2A can all activate neutrophils and were detected in all vaccinees, suggesting that antibody properties were not enhancing, but rather that, in the absence of FcγR3B, these antibody signals did not prevent COVID-19. The gene discussed is FCGR2A; the disease is COVID-19.